These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effect of dronabinol therapy on physical activity in anorexia nervosa: a randomised, controlled trial. Andries A; Gram B; Støving RK Eat Weight Disord; 2015 Mar; 20(1):13-21. PubMed ID: 24890912 [TBL] [Abstract][Full Text] [Related]
4. Serum leptin levels in women with anorexia nervosa. Grinspoon S; Gulick T; Askari H; Landt M; Lee K; Anderson E; Ma Z; Vignati L; Bowsher R; Herzog D; Klibanski A J Clin Endocrinol Metab; 1996 Nov; 81(11):3861-3. PubMed ID: 8923829 [TBL] [Abstract][Full Text] [Related]
5. Relationships between serum adipokines, insulin levels, and bone density in girls with anorexia nervosa. Misra M; Miller KK; Cord J; Prabhakaran R; Herzog DB; Goldstein M; Katzman DK; Klibanski A J Clin Endocrinol Metab; 2007 Jun; 92(6):2046-52. PubMed ID: 17356044 [TBL] [Abstract][Full Text] [Related]
7. The relationship between bone turnover and body weight, serum insulin-like growth factor (IGF) I, and serum IGF-binding protein levels in patients with anorexia nervosa. Hotta M; Fukuda I; Sato K; Hizuka N; Shibasaki T; Takano K J Clin Endocrinol Metab; 2000 Jan; 85(1):200-6. PubMed ID: 10634387 [TBL] [Abstract][Full Text] [Related]
8. Effects of recombinant human insulin-like growth factor (IGF)-I and estrogen administration on IGF-I, IGF binding protein (IGFBP)-2, and IGFBP-3 in anorexia nervosa: a randomized-controlled study. Grinspoon S; Miller K; Herzog D; Clemmons D; Klibanski A J Clin Endocrinol Metab; 2003 Mar; 88(3):1142-9. PubMed ID: 12629097 [TBL] [Abstract][Full Text] [Related]
9. Evidence of a link between resting energy expenditure and bone remodelling, glucose homeostasis and adipokine variations in adolescent girls with anorexia nervosa. Maïmoun L; Guillaume S; Lefebvre P; Philibert P; Bertet H; Picot MC; Gaspari L; Paris F; Seneque M; Dupuys AM; Courtet P; Thomas E; Mariano-Goulart D; Bringer J; Renard E; Sultan C Osteoporos Int; 2016 Jan; 27(1):135-46. PubMed ID: 26245848 [TBL] [Abstract][Full Text] [Related]
11. [Leptin and it's potential role in the pathomechanism of some hormonal and metabolic disorders of patients with anorexia nervosa]. Smiarowska M Ann Acad Med Stetin; 2002; 48():351-65. PubMed ID: 14601488 [TBL] [Abstract][Full Text] [Related]
12. Adipokines, cortisol and cytokine alterations in recent onset anorexia nervosa. A case-control study. Elegido A; Gheorghe A; Sepúlveda AR; Andrés P; Díaz-Prieto LE; Graell M; Marcos A; Nova E Endocrinol Diabetes Nutr (Engl Ed); 2019 Nov; 66(9):571-578. PubMed ID: 30981680 [TBL] [Abstract][Full Text] [Related]
13. Alterations in cortisol secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. Misra M; Miller KK; Almazan C; Ramaswamy K; Lapcharoensap W; Worley M; Neubauer G; Herzog DB; Klibanski A J Clin Endocrinol Metab; 2004 Oct; 89(10):4972-80. PubMed ID: 15472193 [TBL] [Abstract][Full Text] [Related]
14. Serum immunoreactive leptin concentrations in patients with anorexia nervosa before and after partial weight recovery. Casanueva FF; Dieguez C; Popovic V; Peino R; Considine RV; Caro JF Biochem Mol Med; 1997 Apr; 60(2):116-20. PubMed ID: 9169091 [TBL] [Abstract][Full Text] [Related]
16. The effects of recombinant human growth hormone (rhGH) supplementation on adipokines and C-reactive protein in obese subjects. Albert SG; Haas MJ; Mooradian AD Growth Horm IGF Res; 2007 Feb; 17(1):19-25. PubMed ID: 17118687 [TBL] [Abstract][Full Text] [Related]
17. Changes of endocrine function of adipose tissue in anorexia nervosa: comparison of circulating levels versus subcutaneous mRNA expression. Dolezalova R; Lacinova Z; Dolinkova M; Kleiblova P; Haluzikova D; Housa D; Papezova H; Haluzik M Clin Endocrinol (Oxf); 2007 Nov; 67(5):674-8. PubMed ID: 17953628 [TBL] [Abstract][Full Text] [Related]
18. Modulation of adiponectin and leptin during refeeding of female anorexia nervosa patients. Modan-Moses D; Stein D; Pariente C; Yaroslavsky A; Ram A; Faigin M; Loewenthal R; Yissachar E; Hemi R; Kanety H J Clin Endocrinol Metab; 2007 May; 92(5):1843-7. PubMed ID: 17327386 [TBL] [Abstract][Full Text] [Related]
19. Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure. Svensson J; Lönn L; Jansson JO; Murphy G; Wyss D; Krupa D; Cerchio K; Polvino W; Gertz B; Boseaus I; Sjöström L; Bengtsson BA J Clin Endocrinol Metab; 1998 Feb; 83(2):362-9. PubMed ID: 9467542 [TBL] [Abstract][Full Text] [Related]
20. A 4-week pilot study with the cannabinoid receptor agonist dronabinol and its effect on metabolic parameters in a randomized trial. Reichenbach ZW; Sloan J; Rizvi-Toner A; Bayman L; Valestin J; Schey R Clin Ther; 2015 Oct; 37(10):2267-74. PubMed ID: 26283236 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]